Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC
It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…
Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC
The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…
Cannabis companies have high hopes for legalized banking
CNBC’s Jane Wells joins ‘The Exchange’ to discuss the proposed safe banking bill allowing legal cannabis sales to utilize bank services. For access to live and exclusive video from CNBC…
Mastercard has halted cannabis debit transactions before, says Green Check’s Kevin Hart
Kevin Hart, founder and CEO of Green Check, joins ‘The Exchange’ to discuss Mastercard’s decision to ban the purchase of cannabis on debit, the lack of a merchant category code…
The SAFE Banking Bill will catalyze cannabis financial partnerships, says Green Check’s Kevin Hart
Kevin Hart, CEO and co-founder of Green Check Verified, joins ‘The Exchange’ to discuss enthusiasm about the potential passage of the SAFE Banking bill, concerns about the language in the…